PTSD Trial, Recruiting NCT07288008 Sponsor: Birmingham VA Health Care System Condition: PTSD
Back to Ptsd

PTSD Trial, Recruiting

NCT07288008
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have served in the U.S. military as a veteran
  • People who speak English and are willing to sign consent and privacy forms
  • Adults aged 70 years or younger
  • People who scored 10 or higher on the GAD-7 anxiety questionnaire in the past week, which indicates at least a moderate level of anxiety
  • People already taking antidepressants, provided they have been on that medication for at least 8 weeks and at the same dose for at least 4 weeks
  • People who could potentially become pregnant must have a negative pregnancy test at the start of the trial and must agree to use an acceptable form of birth control throughout

Who may not be able to join:

  • People with a lifetime diagnosis of bipolar type I disorder, schizophrenia, or other psychotic disorders, based on VA medical records
  • People with a current problem with misuse of sedatives, sleeping pills, stimulants, inhalants, or opioids within the past 6 months, based on VA records and a clinical interview
  • People diagnosed with moderate to severe alcohol or cannabis use disorder within the past 6 months, based on VA records and a clinical interview
  • People with a history of severe traumatic brain injury, as defined by a specific medical assessment method (confirm with trial site)
  • People with dementia or a related condition that progressively affects memory and thinking, as noted in their medical record
  • People who have taken certain prohibited medications within the past 2 weeks (confirm the specific medication list with the trial site)
  • People considered at high risk of suicide, including those who have had suicidal thoughts or behaviour within the past 90 days, or who screen positive on specific questions of a standard suicide risk questionnaire
  • People who have had electroconvulsive therapy, vagus nerve stimulation, or transcranial magnetic stimulation within the past 6 months
  • People who have an implanted device in their brain or nervous system, such as a deep brain stimulator
  • People who have an implanted cardiac pacemaker
  • People currently experiencing symptoms of trigeminal neuralgia (a nerve condition causing facial pain)
  • People who have received a recognised, evidence-based form of therapy for anxiety, depression, or PTSD within the past 14 days — though people currently in non-evidence-based therapies such as supportive counselling may be eligible if they have been in that therapy for at least 4 weeks before the start of the study
  • People who are pregnant during the treatment period
  • People with a significant medical or surgical condition that would make the trial's electrical brain stimulation treatment unsafe — for example, an unstable heart condition, fear of electrical stimulation, skin irritation or wounds near the electrode sites, or metal fragments (such as shrapnel) near either electrode site
  • People who are currently involved in legal proceedings to claim disability income for a mental health condition outside of the standard VA compensation and pension process

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Lori Davis, MD, Birmingham VA Health Care System

Phone: 205-933-8101

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Birmingham VA Health Care System
Registry
ClinicalTrials.gov
Start date
15 December 2025
Est. completion
30 December 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Generalized Anxiety Disorder 7-item (GAD-7)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov